Efficacy of commercial vaccines against newly emerging avian influenza H5N8 virus in Egypt
Open Access
- 26 June 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 8 (1), 9697
- https://doi.org/10.1038/s41598-018-28057-x
Abstract
The newly emerging, highly pathogenic avian influenza (HPAI) H5N8 virus of clade 2.3.4.4 was recently detected in wild birds and domestic poultry in Egypt in the 2016/2017 winter season. Vaccination based on commercial H5 vaccines is used as an essential control strategy in Egyptian poultry. Here, we studied the efficacy of the eight most common commercial H5 poultry vaccines in the Egyptian market and compared them with an experimental vaccine based on the Egyptian LPAI H5N8 virus that was prepared by using reverse genetics. The experimental vaccine and Re-5 commercial vaccine were able to completely protect chickens and significantly reduce virus shedding. Our results indicate that most of the commercial poultry H5 vaccines used in the present study were ineffective because the seed viruses in these vaccines are genetically distinct from the H5N8 viruses currently circulating in Egypt. Although some of the commercial vaccines protected chickens from mortality, they failed to prevent chickens from shedding the virus. Accordingly, we recommend updating and reinforcing the H5N8 prevention and control strategies in Egypt. The vaccination strategy should be reconsidered based on currently circulating viruses.This publication has 16 references indexed in Scilit:
- Traditional and New Influenza VaccinesClinical Microbiology Reviews, 2013
- Do commercial avian influenza H5 vaccines induce cross-reactive antibodies against contemporary H5N1 viruses in Egypt?Poultry Science, 2013
- Isolation of avian influenza H5N1 virus from vaccinated commercial layer flock in EgyptVirology Journal, 2012
- Diversifying evolution of highly pathogenic H5N1 avian influenza virus in Egypt from 2006 to 2011Virus Genes, 2012
- Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1Veterinary Microbiology, 2011
- Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolateVaccine, 2011
- Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultryProceedings of the National Academy of Sciences of the United States of America, 2010
- Epidemiological Findings of Outbreaks of Disease Caused by Highly Pathogenic H5N1 Avian Influenza Virus in Poultry in Egypt During 2006Avian Diseases, 2008
- Tissue Specificity of Alternative Splicing of Transcripts Encoding Hampin, a New Mouse Protein Homologous to the Drosophila MSL-1 ProteinRussian Journal of Bioorganic Chemistry, 2005
- Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccinesThe Lancet, 2004